January 21, 2011 — The U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee decided that it could not recommend approval of Amyvid (florbetapir) at this time based on the currently available data (13-3); but, voted unanimously (16-0) to recommend approval of Amyvid conditional on a reader training program that demonstrates reader accuracy and consistency through a re-read of previously acquired scans. The committee said efficacy was established and there were no significant safety concerns raised.

Amyvid is an imaging tool indicated for positron emission tomography (PET) imaging of beta-amyloid plaque in the brain. It is being investigated for the potential use in ruling out Alzheimer's disease. In addition to the pivotal phase III "Image-to-Autopsy" study, other clinical studies are also being conducted in the European Union., North and South America, Australia and Asia. The committee stated that a negative scan would be clinically useful in indicating that Alzheimer's pathology is unlikely to be the cause of a patient's cognitive decline.

Lilly acquired Avid Radiopharmaceuticals Inc. in December 2010. Amyvid is Avid's lead candidate and was the first beta-amyloid imaging compound to enter multi-center, investigational new drug (IND) clinical studies in the United States. Amyvid was recently assigned priority review designation by the FDA.

The FDA will consider the panel's recommendation in its review of Amyvid. The FDA takes the advice of its advisory committees into consideration when reviewing investigational drugs, but is not bound by their recommendations.

For more information: www.lilly.com


Related Content

News | Magnetic Resonance Imaging (MRI)

June 2, 2023 — Philips has entered into a collaboration with medical imaging company Polarean to advance the field of ...

Time June 02, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

June 2, 2023 — Ezra, the healthcare artificial intelligence (AI) startup transforming early cancer detection through ...

Time June 02, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

June 2, 2023 — The University of Minnesota and Te Herenga Waka—Victoria University of Wellington, NZ, have received ...

Time June 02, 2023
arrow
News | Point-of-Care Ultrasound (POCUS)

June 1, 2023 —Fujifilm Sonosite, Inc. has added to its leading portfolio of systems with the launch of Sonosite ST ...

Time June 01, 2023
arrow
Feature | Radiology Imaging | By Melinda Taschetta-Millane

It's been a fruitful month for itnonline.com! Here's a look at what ITN viewers found to be most interesting during the ...

Time June 01, 2023
arrow
News | Artificial Intelligence

May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning ...

Time May 31, 2023
arrow
News | Radiopharmaceuticals and Tracers

May 30, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time May 30, 2023
arrow
News | Radiology Business

May 30, 2023 — Strategic Radiology (SR) welcomed 23-radiologist Radiology Associates of Eugene, OR, to the national ...

Time May 30, 2023
arrow
News | Radiology Business

May 26, 2023 — Siemens Healthineers and CommonSpirit Health have agreed to acquire Block Imaging. This new acquisition ...

Time May 26, 2023
arrow
News | Computed Tomography (CT)

May 26, 2023 — GE HealthCare, a leading medical technology innovator, announced today its largest ever CT deal in the ...

Time May 26, 2023
arrow
Subscribe Now